|Mr. David J. Pfanzelter||Chairman||150k||N/A||64|
|Mr. Henry R. Lambert||Chief Exec. Officer and Director||404k||N/A||66|
|Mr. Mark Stuart Elliott||Principal Financial & Accounting Officer and VP of Fin.||165k||N/A||42|
|Mr. Gary L. Primes||VP of Operations||N/A||N/A||N/A|
|Ms. Bridget C. Tinsley-Cormier M.S.||Sr. VP of Technology & Bus. Devel. and VP of Market Devel.||N/A||N/A||N/A|
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a antimicrobial food processing aid for use in poultry processing and produce processing; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.
PURE Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.